AZACITIDINE

CHEBI:CHEBI_747615

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Azacitidine API
brand_name
VIDAZA
brand_name_base
VIDAZA
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
dosage_form
INJECTION, POWDER, FOR SOLUTION
labeler_name
Panacea Biotec Limited
product_ndc
72485-201
application_number
ANDA209337
manufacturer_name
Panacea Biotec Limited
package_marketing_start_date
20040705
package_description
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (72485-201-01)
package_ndc
84172-112-01
listing_expiration_date
20241231
route
INTRAVENOUS
marketing_start_date
20040705
spl_id
e0429a55-e69e-4d8b-9498-46c52b696642
rxcui
2396774
active_ingredient_strength
100 mg/30mL
pharm_class_moa
Nucleic Acid Synthesis Inhibitors [MoA]
pharm_class
Nucleoside Metabolic Inhibitor [EPC]
pharm_class_epc
Nucleoside Metabolic Inhibitor [EPC]
nui
N0000175595
active_ingredient_name
AZACITIDINE
brand_name_suffix
AZACITIDINE
unii
M801H13NRU
spl_set_id
5c0a2d5f-8c34-4c04-8425-7543965cedd4
upc
0316729306102
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class